{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T01:19:38Z","timestamp":1791422378314,"version":"4.3.3"},"reference-count":50,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2015,8,1]],"date-time":"2015-08-01T00:00:00Z","timestamp":1438387200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,8,1]],"date-time":"2015-08-01T00:00:00Z","timestamp":1438387200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["celltherapyjournal.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cytotherapy"],"published-print":{"date-parts":[[2015,8]]},"DOI":"10.1016\/j.jcyt.2015.04.011","type":"journal-article","created":{"date-parts":[[2015,6,13]],"date-time":"2015-06-13T06:56:48Z","timestamp":1434178608000},"page":"1139-1151","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"title":["Cytomegalovirus-specific cytokine-induced killer cells: concurrent targeting of leukemia and cytomegalovirus"],"prefix":"10.1016","volume":"17","author":[{"given":"Verena","family":"Pfirrmann","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Oelsner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Rettinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabine","family":"Huenecke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Halvard","family":"Bonig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Merker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Winfried S.","family":"Wels","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jindrich","family":"Cinatl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ralf","family":"Schubert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Klingebiel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Bader","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcyt.2015.04.011_bib1","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1200\/JCO.2004.05.198","article-title":"Increasing mixed chimerism is an important prognostic factor for unfavorable outcome in children with acute lymphoblastic leukemia after allogeneic stem-cell transplantation: possible role for pre-emptive immunotherapy?","volume":"22","author":"Bader","year":"2004","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.jcyt.2015.04.011_bib2","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1038\/bmt.2013.164","article-title":"Survey of CMV management in pediatric allogeneic HSCT programs, on behalf of the inborn errors, infectious diseases and pediatric diseases working parties of EBMT","volume":"49","author":"Bontant","year":"2014","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jcyt.2015.04.011_bib3","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1038\/leu.2013.106","article-title":"Novel therapies for children with acute myeloid leukaemia","volume":"27","author":"Moore","year":"2013","journal-title":"Leukemia"},{"key":"10.1016\/j.jcyt.2015.04.011_bib4","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1097\/CCO.0b013e328358f62d","article-title":"Current treatment of acute myeloid leukemia","volume":"24","author":"Roboz","year":"2012","journal-title":"Curr Opin Oncol"},{"key":"10.1016\/j.jcyt.2015.04.011_bib5","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1038\/sj.bmt.1705140","article-title":"Cause of death after allogeneic haematopoietic stem cell transplantation (HSCT) in early leukaemias: an EBMT analysis of lethal infectious complications and changes over calendar time","volume":"36","author":"Gratwohl","year":"2005","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jcyt.2015.04.011_bib6","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1182\/blood.V78.5.1373.1373","article-title":"Cytotoxic T-lymphocyte response to cytomegalovirus after human allogeneic bone marrow transplantation: pattern of recovery and correlation with cytomegalovirus infection and disease","volume":"78","author":"Reusser","year":"1991","journal-title":"Blood"},{"key":"10.1016\/j.jcyt.2015.04.011_bib7","unstructured":"Bunos M, H\u00fcmmer C, Wingenfeld E, Sorg N, Pfirrmann V, Bader P, et\u00a0al. Automated isolation of primary antigen-specific T cells from donor lymphocyte concentrates: results of a feasibility exercise donor lymphocyte concentrates: results of a feasibility exercise [published online ahead of print May 7, 2015]. Vox Sanguinis."},{"key":"10.1016\/j.jcyt.2015.04.011_bib8","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1182\/blood-2013-12-547349","article-title":"Lowest numbers of primary CD8+ T cells can reconstitute protective immunity upon adoptive immunotherapy","volume":"124","author":"Stemberger","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.jcyt.2015.04.011_bib9","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1097\/CJI.0000000000000034","article-title":"First-in-man clinical results with good manufacturing practice (GMP)-compliant polypeptide-expanded adenovirus-specific T cells after haploidentical hematopoietic stem cell transplantation","volume":"37","author":"Geyeregger","year":"2014","journal-title":"J.\u00a0Immunother"},{"key":"10.1016\/j.jcyt.2015.04.011_bib10","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.1038\/mt.2013.151","article-title":"Safety and clinical efficacy of rapidly-generated trivirus-directed T cells as treatment for adenovirus, EBV, and CMV infections after allogeneic hematopoietic stem cell transplant","volume":"21","author":"Gerdemann","year":"2013","journal-title":"Mol Ther"},{"key":"10.1016\/j.jcyt.2015.04.011_bib11","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1093\/cid\/ciq042","article-title":"Directly selected cytomegalovirus-reactive donor T cells confer rapid and safe systemic reconstitution of virus-specific immunity following stem cell transplantation","volume":"52","author":"Peggs","year":"2011","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jcyt.2015.04.011_bib12","doi-asserted-by":"crossref","first-page":"1958","DOI":"10.1182\/blood-2009-03-213256","article-title":"Functionally active virus-specific T cells that target CMV, adenovirus, and EBV can be expanded from naive T-cell populations in cord blood and will target a range of viral epitopes","volume":"114","author":"Hanley","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.jcyt.2015.04.011_bib13","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1038\/nm1475","article-title":"Monoculture-derived T lymphocytes specific for multiple viruses expand and produce clinically relevant effects in immunocompromised individuals","volume":"12","author":"Leen","year":"2006","journal-title":"Nat Med"},{"key":"10.1016\/j.jcyt.2015.04.011_bib14","doi-asserted-by":"crossref","first-page":"3745","DOI":"10.1182\/blood-2012-08-448977","article-title":"Donor-derived CMV-specific T cells reduce the requirement for CMV-directed pharmacotherapy after allogeneic stem cell transplantation","volume":"121","author":"Blyth","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.jcyt.2015.04.011_bib15","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1097\/CJI.0b013e31826e35f6","article-title":"Effective treatment of refractory CMV reactivation after allogeneic stem cell transplantation with in\u00a0vitro-generated CMV pp65-specific CD8+ T-cell lines","volume":"35","author":"Meij","year":"2012","journal-title":"J.\u00a0Immunother"},{"key":"10.1016\/j.jcyt.2015.04.011_bib16","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1084\/jem.174.1.139","article-title":"Use of a SCID mouse\/human lymphoma model to evaluate cytokine-induced killer cells with potent antitumor cell activity","volume":"174","author":"Schmidt-Wolf","year":"1991","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.jcyt.2015.04.011_bib17","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.4049\/jimmunol.153.4.1687","article-title":"A\u00a0novel population of expanded human CD3+CD56+ cells derived from T cells with potent in\u00a0vivo antitumor activity in mice with severe combined immunodeficiency","volume":"153","author":"Lu","year":"1994","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.jcyt.2015.04.011_bib18","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1111\/imm.12250","article-title":"Increased numbers and functional activity of CD56\u207a T cells in healthy cytomegalovirus positive subjects","volume":"142","author":"Almehmadi","year":"2014","journal-title":"Immunology"},{"key":"10.1016\/j.jcyt.2015.04.011_bib19","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.3324\/haematol.2009.019885","article-title":"Efficient lysis of rhabdomyosarcoma cells by cytokine-induced killer cells: implications for adoptive immunotherapy after allogeneic stem cell transplantation","volume":"95","author":"Ku\u00e7i","year":"2010","journal-title":"Haematologica"},{"key":"10.1016\/j.jcyt.2015.04.011_bib20","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1093\/intimm\/dxn042","article-title":"Alloreactivity and anti-tumor activity segregate within two distinct subsets of cytokine-induced killer (CIK) cells: implications for their infusion across major HLA barriers","volume":"20","author":"Sangiolo","year":"2008","journal-title":"Int Immunol"},{"key":"10.1016\/j.jcyt.2015.04.011_bib21","doi-asserted-by":"crossref","first-page":"3065","DOI":"10.1182\/blood-2003-06-2125","article-title":"Role of NKG2D signaling in the cytotoxicity of activated and expanded CD8+ T cells","volume":"103","author":"Verneris","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.jcyt.2015.04.011_bib22","doi-asserted-by":"crossref","first-page":"91","DOI":"10.3109\/14653249.2011.613931","article-title":"The cytotoxic potential of interleukin-15-stimulated cytokine-induced killer cells against leukemia cells","volume":"14","author":"Rettinger","year":"2012","journal-title":"Cytotherapy"},{"key":"10.1016\/j.jcyt.2015.04.011_bib23","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.4049\/jimmunol.1302053","article-title":"Human cytomegalovirus infection promotes rapid maturation of NK cells expressing activating killer Ig-like receptor in patients transplanted with NKG2C-\/- umbilical cord blood","volume":"192","author":"Della Chiesa","year":"2014","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.jcyt.2015.04.011_bib24","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1182\/blood-2008-05-157354","article-title":"Human NK cells can control CMV infection in the absence of T cells","volume":"112","author":"Kuijpers","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.jcyt.2015.04.011_bib25","doi-asserted-by":"crossref","first-page":"3301","DOI":"10.1182\/blood-2011-02-336321","article-title":"Dual-functional capability of CD3+CD56+ CIK cells, a T-cell subset that acquires NK function and retains TCR-mediated specific cytotoxicity","volume":"118","author":"Pievani","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.jcyt.2015.04.011_bib26","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1007\/s00018-010-0510-8","article-title":"The multi-targeted kinase inhibitor sorafenib inhibits human cytomegalovirus replication","volume":"68","author":"Michaelis","year":"2011","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.jcyt.2015.04.011_bib27","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/j.jcyt.2014.01.003","article-title":"Immunomagnetic selection or irradiation eliminates alloreactive cells but also reduces anti-tumor potential of cytokine-induced killer cells: implications for unmanipulated cytokine-induced killer cell infusion","volume":"16","author":"Rettinger","year":"2014","journal-title":"Cytotherapy"},{"key":"10.1016\/j.jcyt.2015.04.011_bib28","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1007\/BF00510085","article-title":"Colorimetric growth assay for epidermal cell cultures by their crystal violet binding capacity","volume":"281","author":"Bonnekoh","year":"1989","journal-title":"Arch Dermatol Res"},{"key":"10.1016\/j.jcyt.2015.04.011_bib29","doi-asserted-by":"crossref","first-page":"391","DOI":"10.3109\/14653249.2012.662769","article-title":"The role of virus-specific adoptive T-cell therapy in hematopoietic transplantation","volume":"14","author":"Sellar","year":"2012","journal-title":"Cytotherapy"},{"key":"10.1016\/j.jcyt.2015.04.011_bib30","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1093\/cid\/cis625","article-title":"Rapid salvage treatment with virus-specific T cells for therapy-resistant disease","volume":"55","author":"Uhlin","year":"2012","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jcyt.2015.04.011_bib31","doi-asserted-by":"crossref","first-page":"4360","DOI":"10.1182\/blood-2010-01-262089","article-title":"Adoptive transfer of pp65-specific T cells for the treatment of chemorefractory cytomegalovirus disease or reactivation after haploidentical and matched unrelated stem cell transplantation","volume":"116","author":"Feuchtinger","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.jcyt.2015.04.011_bib32","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1080\/146532402317251509","article-title":"Flow cytometric quantitation and characterization of the T-lymphocyte memory response to CMV in healthy donors","volume":"4","author":"Hensel","year":"2002","journal-title":"Cytotherapy"},{"key":"10.1016\/j.jcyt.2015.04.011_bib33","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1111\/j.1365-2567.2008.02910.x","article-title":"Characterization of the recognition and functional heterogeneity exhibited by cytokine-induced killer cell subsets against acute myeloid leukaemia target cell","volume":"126","author":"Linn","year":"2009","journal-title":"Immunology"},{"key":"10.1016\/j.jcyt.2015.04.011_bib34","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1517\/14712590903005552","article-title":"Cytokine induced killer cells as adoptive immunotherapy strategy to augment graft versus tumor after hematopoietic cell transplantation","volume":"9","author":"Sangiolo","year":"2009","journal-title":"Expert Opin Biol Ther"},{"key":"10.1016\/j.jcyt.2015.04.011_bib35","first-page":"1673","article-title":"Phenotypic characterization and identification of effector cells involved in tumor cell recognition of cytokine-induced killer cells","volume":"21","author":"Schmidt-Wolf","year":"1993","journal-title":"Exp Hematol"},{"key":"10.1016\/j.jcyt.2015.04.011_bib36","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/0008-8749(91)90369-M","article-title":"Comparative studies of CD3- and CD3+ CD56+ cells: examination of morphology, functions, T cell receptor rearrangement, and pore-forming protein expression","volume":"136","author":"Ortaldo","year":"1991","journal-title":"Cell Immunol"},{"key":"10.1016\/j.jcyt.2015.04.011_bib37","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.trim.2006.04.002","article-title":"Effect of interleukin-15 on alloreactivity in umbilical cord blood","volume":"16","author":"Lin","year":"2006","journal-title":"Transpl Immunol"},{"key":"10.1016\/j.jcyt.2015.04.011_bib38","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1182\/blood-2004-05-1687","article-title":"Donor-derived IL-15 is critical for acute allogeneic graft-versus-host disease","volume":"105","author":"Blaser","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.jcyt.2015.04.011_bib39","doi-asserted-by":"crossref","first-page":"851","DOI":"10.3109\/14653249.2012.694419","article-title":"A\u00a0phase I\/II clinical trial of autologous cytokine-induced killer cells as adjuvant immunotherapy for acute and chronic myeloid leukemia in clinical remission","volume":"14","author":"Linn","year":"2012","journal-title":"Cytotherapy"},{"key":"10.1016\/j.jcyt.2015.04.011_bib40","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1016\/j.bbmt.2011.05.012","article-title":"Adoptive immunotherapy with cytokine-induced killer cells for patients with relapsed hematologic malignancies after allogeneic hematopoietic cell transplantation","volume":"17","author":"Laport","year":"2011","journal-title":"Biol. Blood Marrow Transplant"},{"key":"10.1016\/j.jcyt.2015.04.011_bib41","doi-asserted-by":"crossref","first-page":"952","DOI":"10.3324\/haematol.11132","article-title":"Repeated infusions of donor-derived cytokine-induced killer cells in patients relapsing after allogeneic stem cell transplantation: a phase I study","volume":"92","author":"Introna","year":"2007","journal-title":"Haematologica"},{"key":"10.1016\/j.jcyt.2015.04.011_bib42","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1038\/bmt.2013.19","article-title":"Feasibility of IL-15-activated cytokine-induced killer cell infusions after haploidentical stem cell transplantation","volume":"48","author":"Rettinger","year":"2013","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jcyt.2015.04.011_bib43","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1038\/leu.2012.374","article-title":"\u03b3\u03b4T cells elicited by CMV reactivation after allo-SCT cross-recognize CMV and leukemia","volume":"27","author":"Scheper","year":"2013","journal-title":"Leukemia"},{"key":"10.1016\/j.jcyt.2015.04.011_bib44","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/j.exphem.2009.01.010","article-title":"Cytokine-induced killer cells are terminally differentiated activated CD8 cytotoxic T-EMRA lymphocytes","volume":"37","author":"Franceschetti","year":"2009","journal-title":"Exp Hematol"},{"key":"10.1016\/j.jcyt.2015.04.011_bib45","first-page":"594","article-title":"Superior T memory stem cell persistence supports long-lived T cell memory","volume":"123","author":"Lugli","year":"2013","journal-title":"J.\u00a0Clin. Invest"},{"key":"10.1016\/j.jcyt.2015.04.011_bib46","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.immuni.2007.07.010","article-title":"Inflammation directs memory precursor and short-lived effector CD8(+) T cell fates via the graded expression of T-bet transcription factor","volume":"27","author":"Joshi","year":"2007","journal-title":"Immunity"},{"key":"10.1016\/j.jcyt.2015.04.011_bib47","doi-asserted-by":"crossref","first-page":"5425","DOI":"10.4049\/jimmunol.173.9.5425","article-title":"The selective increase in caspase-3 expression in effector but not memory T cells allows susceptibility to apoptosis","volume":"173","author":"Sabbagh","year":"2004","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.jcyt.2015.04.011_bib48","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1038\/nri2800","article-title":"Innate IL-17-producing cells: the sentinels of the immune system","volume":"10","author":"Cua","year":"2010","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.jcyt.2015.04.011_bib49","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1146\/annurev.immunol.15.1.749","article-title":"Cellular responses to interferon-gamma","volume":"15","author":"Boehm","year":"1997","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.jcyt.2015.04.011_bib50","doi-asserted-by":"crossref","first-page":"2563","DOI":"10.1182\/blood-2007-06-092817","article-title":"In\u00a0vivo trafficking and survival of cytokine-induced killer cells resulting in minimal GVHD with retention of antitumor activity","volume":"112","author":"Nishimura","year":"2008","journal-title":"Blood"}],"container-title":["Cytotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1465324915008841?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1465324915008841?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T22:21:37Z","timestamp":1761430897000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1465324915008841"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,8]]},"references-count":50,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2015,8]]}},"alternative-id":["S1465324915008841"],"URL":"https:\/\/doi.org\/10.1016\/j.jcyt.2015.04.011","relation":{},"ISSN":["1465-3249"],"issn-type":[{"value":"1465-3249","type":"print"}],"subject":[],"published":{"date-parts":[[2015,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cytomegalovirus-specific cytokine-induced killer cells: concurrent targeting of leukemia and cytomegalovirus","name":"articletitle","label":"Article Title"},{"value":"Cytotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcyt.2015.04.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 International Society for Cellular Therapy. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}